keyword
https://read.qxmd.com/read/38479748/understanding-and-maximising-the-community-impact-of-seasonal-malaria-chemoprevention-in-burkina-faso-indie-smc-study-protocol-for-a-cluster-randomised-evaluation-trial
#1
JOURNAL ARTICLE
Marta Moreno, Aissata Barry, Markus Gmeiner, Jean Baptist Yaro, Samuel S Sermé, Isabel Byrne, Jordache Ramjith, Alphonse Ouedraogo, Issiaka Soulama, Lynn Grignard, Seyi Soremekun, Simon Koele, Rob Ter Heine, Amidou Z Ouedraogo, Jean Sawadogo, Edith Sanogo, Issa N Ouedraogo, Denise Hien, Sodiomon Bienvenu Sirima, John Bradley, Teun Bousema, Chris Drakeley, Alfred B Tiono
INTRODUCTION: Seasonal malaria chemoprevention (SMC) involves repeated administrations of sulfadoxine-pyrimethamine plus amodiaquine to children below the age of 5 years during the peak transmission season in areas of seasonal malaria transmission. While highly impactful in reducing Plasmodium falciparum malaria burden in controlled research settings, the impact of SMC on infection prevalence is moderate in real-life settings. It remains unclear what drives this efficacy decay. Recently, the WHO widened the scope for SMC to target all vulnerable populations...
March 12, 2024: BMJ Open
https://read.qxmd.com/read/38472909/lipid-peroxidation-in-muscle-foods-impact-on-quality-safety-and-human-health
#2
REVIEW
Stefan G Dragoev
The issue of lipid changes in muscle foods under the action of atmospheric oxygen has captured the attention of researchers for over a century. Lipid oxidative processes initiate during the slaughtering of animals and persist throughout subsequent technological processing and storage of the finished product. The oxidation of lipids in muscle foods is a phenomenon extensively deliberated in the scientific community, acknowledged as one of the pivotal factors affecting their quality, safety, and human health...
March 4, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38350825/fourth-controlled-human-infection-model-chim-meeting-chims-in-endemic-countries-may-22-23-2023
#3
JOURNAL ARTICLE
Melissa Kapulu, Lucinda Manda-Taylor, Shobana Balasingam, Gary Means, Mikal Ayiro Malungu, Philip Bejon, Primus Che Chi, Christopher Chiu, E Chandler Church, Rodrigo Correa-Oliveira, Nicholas Day, Anna Durbin, Moses Egesa, Claudia Emerson, Kondwani Jambo, Roli Mathur, Wolfram Metzger, Noni Mumba, Winfred Nazziwa, Ally Olotu, Jacqueline Rodgers, Frank Sinyiza, Kawsar Talaat, Ingrid Kamerling, Charlie Weller, Marc Baay, Pieter Neels
Earlier meetings laid the foundations for Controlled Human Infection Models (CHIMs), also known as human challenge studies and human infection studies, including Good Manufacturing Practice (GMP) production of the challenge agent, CHIM ethics, environmental safety in CHIM, recruitment, community engagement, advertising and incentives, pre-existing immunity, and clinical, immunological, and microbiological endpoints. The fourth CHIM meeting focused on CHIM studies being conducted in endemic countries. Over the last ten years we have seen a vast expansion of the number of countries in Africa performing CHIM studies, as well as a growing number of different challenge organisms being used...
February 12, 2024: Biologicals: Journal of the International Association of Biological Standardization
https://read.qxmd.com/read/38350349/ethical-approval-for-controlled-human-infectious-model-clinical-trial-protocols-a-workshop-report
#4
JOURNAL ARTICLE
Euzebiusz Jamrozik, Katherine Littler, Irina Meln, Wim Van Molle, Sandra Morel, Ole F Olesen, Michelle Rubbrecht, Shobana Balasingam, Pieter Neels
Controlled Human Infectious Model studies (CHIM) involve deliberately exposing volunteers to pathogens. To discuss ethical issues related to CHIM, the European Vaccine Initiative and the International Alliance for Biological Standardization organised the workshop "Ethical Approval for CHIM Clinical Trial Protocols", which took place on May 30-31, 2023, in Brussels, Belgium. The event allowed CHIM researchers, regulators, ethics committee (EC) members, and ethicists to examine the ethical criteria for CHIM and the role(s) of CHIM in pharmaceutical development...
February 12, 2024: Biologicals: Journal of the International Association of Biological Standardization
https://read.qxmd.com/read/38341355/fourth-controlled-human-infection-model-chim-meeting-chim-regulatory-issues-may-24-2023
#5
JOURNAL ARTICLE
Marco Cavaleri, David Kaslow, Eric Boateng, Wilbur H Chen, Christopher Chiu, Robert K M Choy, Rodrigo Correa-Oliveira, Anna Durbin, Moses Egesa, Malick Gibani, Melissa Kapulu, Melba Katindi, Ally Olotu, Pongphaya Pongsuwan, Michelo Simuyandi, Bruno Speder, Kawsar R Talaat, Charlie Weller, Bridget Wills, Marc Baay, Shobana Balasingam, Ole F Olesen, Pieter Neels
Many aspects of Controlled Human Infection Models (CHIMs, also known as human challenge studies and human infection studies) have been discussed extensively, including Good Manufacturing Practice (GMP) production of the challenge agent, CHIM ethics, environmental safety in CHIM, recruitment, community engagement, advertising and incentives, pre-existing immunity, and clinical, immunological, and microbiological endpoints. The fourth CHIM meeting focused on regulation of CHIM studies, bringing together scientists and regulators from high-, middle-, and low-income countries, to discuss barriers and hurdles in CHIM regulation...
February 10, 2024: Biologicals: Journal of the International Association of Biological Standardization
https://read.qxmd.com/read/38154488/the-nairobi-declaration-2023-a-commitment-to-address-deadly-yet-neglected-fungal-diseases-in-africa
#6
JOURNAL ARTICLE
Iriagbonse I Osaigbovo, Nelesh P Govender, Alexander M Jordan, Felix Bongomin, David B Meya, Alice Kanyua, Olga M Mashedi, David Koffi, Angela Loyse, Aude Sturny-Leclère, Jean-Pierre Gangneux, David W Denning, Tom Chiller, Oliver Cornely, Rita O Oladele
On May 30th and 31st, 2023, delegates representing various African subregions, together with global representatives from the International Society of Human and Animal Mycology (ISHAM), European Confederation of Medical Mycology (ECMM,) United States Centre for Disease Control and Prevention (CDC) and Global Action for Fungal Infections (GAFFI), convened in Nairobi, Kenya under the aegis of the Pan African Mycology Working Group, a working group of ISHAM. The meeting objectives were, amongst others, to deliberate on a continental response to the World Health Organization Fungal Priority Pathogen List and facilitate interaction between global and regional leaders...
December 28, 2023: Medical Mycology
https://read.qxmd.com/read/38136827/ameliorative-effect-of-pomegranate-peel-powder-on-the-growth-indices-oocysts-shedding-and-intestinal-health-of-broilers-under-an-experimentally-induced-coccidiosis-condition
#7
JOURNAL ARTICLE
Abdul Hafeez, Qambar Piral, Shabana Naz, Mikhlid H Almutairi, Abdulwahed Fahad Alrefaei, Tugay Ayasan, Rifat Ullah Khan, Caterina Losacco
Coccidiosis stands as one of the most prevalent enteric parasitic diseases in broilers. While antibiotics have traditionally been used for the control of coccidiosis, concerns related to drug residues and the emergence of resistance in chickens have prompted consumer apprehensions. In this study, 600 Ross 308 broiler chicks were randomly divided into five groups: a control group without specific treatments (NC), broilers deliberately exposed to Eimeria tenella (positive control), broilers challenged with E...
December 8, 2023: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/38011766/female-genital-mutilation-an-overview-for-forensic-practitioners
#8
REVIEW
Roger W Byard, Fariba Behnia-Willison
Female genital mutilation (FGM) refers to all procedures that partially or totally remove the external female genitalia, or to all other deliberate injuries to the female genital organs for non-medical reasons. It is thought that over 200 million girls and women have had some form of FGM, with more than three million girls being at risk annually. The procedure varies in severity from partial or complete removal of the clitoris (Type 1) to oversewing of the vaginal opening, so-called infibulation (Type 3). There are no medical benefits from FGM, with complications increasing with the amount of tissue damage that has been inflicted...
November 22, 2023: Journal of Forensic and Legal Medicine
https://read.qxmd.com/read/38007589/plasma-disinfection-procedures-for-surfaces-in-emergency-service-vehicles-a-field-trial-at-the-german-red-cross
#9
JOURNAL ARTICLE
Tom Schaal, Ulrich Schmelz
The demand for thorough disinfection within ambulances is essential, given the in-vehicle medical procedures and the potential high risk of infections due to patients' open wounds. One solution that can address this hygiene challenge involves the application of reactive products generated from atmospheric (air) oxygen and water vapor, activated through the use of cold plasma. Cold plasma's charged particles perforate the cell membranes of microorganisms. This process does not work in human cells, as proteins in the form of enzymes within the body break down the cold plasma and protect the cells...
November 25, 2023: Scientific Reports
https://read.qxmd.com/read/38003150/effect-of-lemon-citrus-limon-l-peel-powder-on-oocyst-shedding-intestinal-health-and-performance-of-broilers-exposed-to-e-tenella-challenge
#10
JOURNAL ARTICLE
Abdul Hafeez, Israr Ahmad, Shabana Naz, Rasha Alonaizan, Rasha K Al-Akeel, Rifat Ullah Khan, Vincenzo Tufarelli
To date, no study has reported the anticoccidial effect of lemon peel powder in broilers. Coccidiosis, caused by Eimeria species, is the prevalent enteric parasitic disease in poultry. Although certain chemical drugs have been used for their control, concerns regarding drug residues and the development of resistance in chickens have arisen among consumers. In this study, a total of 300 Ross 308 broiler chicks were randomly allocated into five groups (five equal replicates of 12 animals). The first group served as the control and did not receive any specific treatment (NC)...
November 15, 2023: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/37791226/a-case-of-omphalitis-revealing-alloimmune-neonatal-neutropenia
#11
Nasa Machimoto, Yosuke Baba, Yuri Takaoka, Hiromichi Shoji, Toshiaki Shimizu
Neutropenia, characterized by a decrease in peripheral blood neutrophil count less than 1500/µL, poses significant clinical challenges due to its association with recurrent infections. This paper presents a rare and intriguing case of alloimmune neonatal neutropenia (ANN), an uncommon variant of neutropenia instigated by the transplacental transfer of maternal anti-neutrophil antibodies that consequently induce opsonization and phagocytosis of the neonate's neutrophils within the reticuloendothelial system...
August 2023: Curēus
https://read.qxmd.com/read/37721594/the-case-for-human-challenge-trials-in-covid-19
#12
JOURNAL ARTICLE
George P Drewett
The COVID-19 pandemic has necessitated rapid research to aid in the understanding of the disease and the development of novel therapeutics. One option is to conduct controlled human infection trials (CHITs). In this article I examine the history of deliberate human infection and CHITs and their utilization prior to the COVID-19 pandemic, key ethical considerations of CHITs in the COVID-19 setting, an analysis of the World Health Organization's (WHO) Key criteria for the ethical acceptability of COVID-19 human challenge studies, and a review of the two COVID-19 CHITs that have already commenced, their compliance with the WHO criteria and other ethical considerations...
September 18, 2023: Journal of Bioethical Inquiry
https://read.qxmd.com/read/37716911/ethical-requirements-for-human-challenge-studies-a-systematic-review-of-reasons
#13
REVIEW
Matthias Katzer, Sabine Salloch, Christoph Schindler, Marcel Mertz
Human challenge studies (HCS) are controlled clinical trials in which participants are deliberately infected with a pathogen. Such trials are being developed for an increasing number of diseases. Partly as a result of the COVID-19 pandemic, there has been a recent ethical debate about the reasons for and against HCS in general, or rather, about the requirements that individual HCS must fulfill to be ethically acceptable. A systematic review was conducted to categorize and summarize such requirements and the reasons given for them...
September 16, 2023: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/37699711/protein-based-nanocarriers-and-nanotherapeutics-for-infection-and-inflammation
#14
JOURNAL ARTICLE
Nupur Nagar, Goutami Naidu, Amit Mishra, Krishna Mohan Poluri
Infectious and inflammatory diseases are one of the leading causes of death globally. The status quo has become more prominent with the onset of Covid-19 pandemic. In order to combat these potential crises, proteins have been proven as highly efficacious drugs, drug targets and biomarkers. On the other hand, advancements in nanotechnology have aided efficient and sustained drug delivery due to their nano-dimension-acquired advantages. Combining both the strategies together, the protein nanoplatforms are equipped with the advantageous intrinsic properties of proteins as well as nanoformulations, eloquently changing the field of nanomedicine...
September 12, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/37670362/moral-lessons-from-residents-close-relatives-and-volunteers-about-the-covid-19-restrictions-in-dutch-and-flemish-nursing-homes
#15
JOURNAL ARTICLE
Elleke Landeweer, Nina Hovenga, Suzie Noten, Floor Vinckers, Jasper de Witte, Annerieke Stoop, Sytse Zuidema
BACKGROUND: During the COVID-19 outbreak in 2020, national governments took restrictive measures, such as a visitors ban, prohibition of group activities and quarantine, to protect nursing home residents against infections. As 'safety' prevailed, residents and close relatives had no choice but to accept the restrictions. Their perspectives are relevant because the policies had a major impact on them, but they were excluded from the policy decisions. In this study we looked into the moral attitudes of residents, close relatives and volunteers regarding the restrictions in retrospect, and what moral lessons they considered important...
September 6, 2023: Philosophy, Ethics, and Humanities in Medicine: PEHM
https://read.qxmd.com/read/37579202/ethics-of-controlled-human-infection-studies-with-hepatitis-c-virus
#16
JOURNAL ARTICLE
Annette Rid, Jordan J Feld, T Jake Liang, Charles Weijer
Global elimination of hepatitis C virus (HCV) will be difficult to attain without an effective HCV vaccine. Controlled human infection (CHI) studies with HCV were not considered until recently, when highly effective treatment became available. However, now that successful treatment of a deliberate HCV infection is feasible, it is imperative to evaluate the ethics of establishing a program of HCV CHI research. Here, we evaluate the ethics of studies to develop an HCV CHI model in light of 10 ethical considerations: sufficient social value, reasonable risk-benefit profile, suitable site selection, fair participant selection, robust informed consent, proportionate compensation or payment, context-specific stakeholder engagement, fair and open collaboration, independent review and oversight, and integrated ethics research...
August 14, 2023: Clinical Infectious Diseases
https://read.qxmd.com/read/37542500/outcomes-of-arterial-bypass-with-the-human-acellular-vessel-for-chronic-limb-threatening-ischemia-performed-under-the-fda-expanded-access-program
#17
JOURNAL ARTICLE
Indrani Sen, W Darrin Clouse, Alexis L Lauria, Daniel R Calderon, Peter B Anderson, Randall R DeMartino, Todd E Rasmussen
OBJECTIVE: To report outcomes of the human acellular vessel (HAV) implanted for limb salvage through the Food and Drug Administration (FDA) Expanded Access Program for patients with chronic limb-threatening ischemia with no autologous conduit. METHODS: The HAV is a bioengineered vascular conduit designed with human vascular smooth muscle cells. The product is under regulatory study. From April 2019 to November 2021, the HAV was implanted in 14 patients (12 men; mean age, 62±14 years) at 3 US centers...
August 2, 2023: Mayo Clinic Proceedings
https://read.qxmd.com/read/37533532/pneumonia-knowledge-and-care-seeking-behavior-for-children-under-five-years-in-jigawa-northwest-nigeria-a-cross-sectional-study
#18
JOURNAL ARTICLE
Ayobami A Bakare, Carina King, Julius Salako, Damola Bakare, Obioma C Uchendu, Rochelle Ann Burgess, Funmilayo Shittu, Agnese Iuliano, Adamu Isah, Tahlil Ahmed, Samy Ahmar, Paula Valentine, Temitayo Folorunso Olowookere, Eric D McCollum, Tim Colbourn, Adegoke G Falade, Hamish R Graham
BACKGROUND: Between 2013 and 2022, Nigeria did not meet globally defined targets for pneumonia control, despite some scale-up of vaccinations, oxygen and antibiotics. A deliberate focus on community-based programs is needed to improve coverage of protective, preventive and treatment interventions. We therefore aimed to describe caregiver knowledge and care seeking behaviour for childhood pneumonia, in a high child mortality setting in Nigeria, to inform the development of effective community-based interventions for pneumonia control...
2023: Frontiers in Public Health
https://read.qxmd.com/read/37338856/viral-infections-at-the-animal-human-interface-learning-lessons-from-the-sars-cov-2-pandemic
#19
JOURNAL ARTICLE
Harald Brüssow
This Lilliput explores the current epidemiological and virological arguments for a zoonotic origin of the COVID-19 pandemic. While the role of bats, pangolins and racoon dogs as viral reservoirs has not yet been proven, a spill-over of a coronavirus infection from animals into humans at the Huanan food market in Wuhan has a much greater plausibility than alternative hypotheses such as a laboratory virus escape, deliberate genetic engineering or introduction by cold chain food products. This Lilliput highlights the dynamic nature of the animal-human interface for viral cross-infections from humans into feral white tail deer or farmed minks (reverse zoonosis)...
July 2023: Microbial Biotechnology
https://read.qxmd.com/read/37304270/controlled-human-infection-models-in-covid-19-and-tuberculosis-current-progress-and-future-challenges
#20
REVIEW
Hazel Morrison, Susan Jackson, Helen McShane
Controlled Human Infection Models (CHIMs) involve deliberately exposing healthy human volunteers to a known pathogen, to allow the detailed study of disease processes and evaluate methods of treatment and prevention, including next generation vaccines. CHIMs are in development for both tuberculosis (TB) and Covid-19, but challenges remain in their ongoing optimisation and refinement. It would be unethical to deliberately infect humans with virulent Mycobacteria tuberculosis ( M.tb ), however surrogate models involving other mycobacteria, M...
2023: Frontiers in Immunology
keyword
keyword
95172
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.